CHEK1 and head and neck squamous cell carcinoma: Three HPV-negative HNSCC lines (UM-SCC-22A, UM-SCC-38 and VU-SCC-OE) were very sensitive to Chk1 inhibition with EC50 < 200 nM after 72 h treatment.